Published in Scand J Immunol on November 01, 1996
A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J Exp Med (1999) 2.32
Serum amyloid A: an acute-phase protein involved in tumour pathogenesis. Cell Mol Life Sci (2009) 1.57
Serum amyloid A, properdin, complement 3, and toll-like receptors are expressed locally in human sinonasal tissue. Am J Rhinol (2006) 1.03
Identifying viral infections in vaccinated Chronic Obstructive Pulmonary Disease (COPD) patients using clinical features and inflammatory markers. Influenza Other Respir Viruses (2010) 0.83
Organization and biology of the porcine serum amyloid A (SAA) gene cluster: isoform specific responses to bacterial infection. PLoS One (2013) 0.81
Deficiency of Endogenous Acute-Phase Serum Amyloid A Protects apoE-/- Mice From Angiotensin II-Induced Abdominal Aortic Aneurysm Formation. Arterioscler Thromb Vasc Biol (2015) 0.77
Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis. PLoS One (2017) 0.75
Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem (1999) 4.94
The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. QJM (1996) 3.31
The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today (1994) 3.13
Molecular map of the murine S region. Proc Natl Acad Sci U S A (1983) 2.24
Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet (1997) 2.10
Warfarin response and vitamin K epoxide reductase complex 1 in African Americans and Caucasians. Clin Pharmacol Ther (2007) 2.01
Polymorphism of the human complement C4 and steroid 21-hydroxylase genes. Restriction fragment length polymorphisms revealing structural deletions, homoduplications, and size variants. J Clin Invest (1986) 2.00
Assignment of the structural gene for the third component of human complement to chromosome 19. Proc Natl Acad Sci U S A (1982) 2.00
The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet (1999) 1.94
Dosing algorithms to predict warfarin maintenance dose in Caucasians and African Americans. Clin Pharmacol Ther (2008) 1.90
Regulation of serum amyloid A protein expression during the acute-phase response. Biochem J (1998) 1.83
Use of a cDNA clone for the fourth component of human complement (C4) for analysis of a genetic deficiency of C4 in guinea pig. Proc Natl Acad Sci U S A (1983) 1.82
Characterization of genomic and complementary DNA sequence of human C-reactive protein, and comparison with the complementary DNA sequence of serum amyloid P component. J Biol Chem (1985) 1.79
Apolipoprotein E genotype and warfarin dosing among Caucasians and African Americans. Pharmacogenomics J (2007) 1.78
Molecular characterization of sialophorin (CD43), the lymphocyte surface sialoglycoprotein defective in Wiskott-Aldrich syndrome. Proc Natl Acad Sci U S A (1989) 1.73
Effect of B-group vitamins and antioxidant vitamins on hyperhomocysteinemia: a double-blind, randomized, factorial-design, controlled trial. Am J Clin Nutr (1998) 1.56
The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis (2001) 1.53
Phase I clinical and pharmacogenetic trial of irinotecan and raltitrexed administered every 21 days to patients with cancer. J Clin Oncol (2001) 1.50
Methylenetetrahydrofolate reductase genotypes and predisposition to atherothrombotic disease; evidence that all three MTHFR C677T genotypes confer different levels of risk. Eur Heart J (2001) 1.49
Human serum amyloid A (SAA): biosynthesis and postsynthetic processing of preSAA and structural variants defined by complementary DNA. Biochemistry (1985) 1.49
Human serum amyloid P component. cDNA isolation, complete sequence of pre-serum amyloid P component, and localization of the gene to chromosome 1. J Biol Chem (1985) 1.47
Pretranslational regulation of the synthesis of the third component of complement in human mononuclear phagocytes by the lipid A portion of lipopolysaccharide. J Clin Invest (1985) 1.45
Serum amyloid A in the assessment of early inflammatory arthritis. J Rheumatol (2000) 1.38
Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet Epidemiol (1999) 1.30
Evolution of the serum amyloid A (SAA) protein superfamily. Genomics (1994) 1.21
The human C-reactive protein gene (CRP) and serum amyloid P component gene (APCS) are located on the proximal long arm of chromosome 1. Immunogenetics (1986) 1.21
Acute-phase serum amyloid A production by rheumatoid arthritis synovial tissue. Arthritis Res (2000) 1.21
Complementary DNA and derived amino acid sequence of the alpha subunit of human complement protein C8: evidence for the existence of a separate alpha subunit messenger RNA. Biochemistry (1987) 1.20
Regulation of the human acute phase serum amyloid A genes by tumour necrosis factor-alpha, interleukin-6 and glucocorticoids in hepatic and epithelial cell lines. Scand J Immunol (2004) 1.20
IL-1 signaling cascade in liver cells and the involvement of a soluble form of the IL-1 receptor accessory protein. J Immunol (2000) 1.19
DNA polymorphism of the C4 genes. A new marker for analysis of the major histocompatibility complex. N Engl J Med (1984) 1.19
Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation. Circulation (1996) 1.16
Molecular characterization of the mouse mannose-binding proteins. The mannose-binding protein A but not C is an acute phase reactant. J Immunol (1991) 1.15
IRAK1b, a novel alternative splice variant of interleukin-1 receptor-associated kinase (IRAK), mediates interleukin-1 signaling and has prolonged stability. J Biol Chem (2001) 1.14
The evolution of haematopoietic cytokine/receptor complexes. Cytokine (1995) 1.14
Functional modeling of vitamin responsiveness in yeast: a common pyridoxine-responsive cystathionine beta-synthase mutation in homocystinuria. Hum Mol Genet (1997) 1.13
Are common mutations of cystathionine beta-synthase involved in the aetiology of neural tube defects? Clin Genet (1997) 1.13
Whole-blood folate values in subjects with different methylenetetrahydrofolate reductase genotypes: differences between the radioassay and microbiological assays. Clin Chem (1998) 1.10
High frequency (71%) of cystathionine beta-synthase mutation G307S in Irish homocystinuria patients. Hum Mutat (1995) 1.03
Human inhibitor of the first component of complement, C1: characterization of cDNA clones and localization of the gene to chromosome 11. Proc Natl Acad Sci U S A (1986) 1.03
Amyloid precursors and amyloidosis in rheumatoid arthritis. Baillieres Best Pract Res Clin Rheumatol (1999) 1.02
Isolation of human C-reactive protein complementary DNA and localization of the gene to chromosome 1. Science (1983) 1.02
The mouse interleukin 1 receptor antagonist protein: gene structure and regulation in vitro. Cytokine (1994) 1.02
Localization of the human MHC-linked complement genes between HLA-B and HLA-DR by using HLA mutant cell lines. J Immunol (1985) 1.01
A monoclonal antibody against human complement component C3: the production of C3 by human cells in vitro. Eur J Immunol (1981) 1.01
Parkinson's, Alzheimer's, and motor neurone disease. BMJ (1996) 1.00
Nucleotide sequence and expression of the human gene encoding apolipoprotein H (beta 2-glycoprotein I). Gene (1991) 0.99
Biosynthesis of human acute-phase serum amyloid A protein (A-SAA) in vitro: the roles of mRNA accumulation, poly(A) tail shortening and translational efficiency. Biochem J (1993) 0.99
Analysis of the human Sonic Hedgehog coding and promoter regions in sacral agenesis, triphalangeal thumb, and mirror polydactyly. Hum Genet (1998) 0.99
Radioimmunoassay for the determination of alosetron in human urine and saliva. Analyst (1994) 0.97
Biosynthesis and postsynthetic processing of human C-reactive protein. J Immunol (1983) 0.97
Low blood folates in NTD pregnancies are only partly explained by thermolabile 5,10-methylenetetrahydrofolate reductase: low folate status alone may be the critical factor. Am J Med Genet (1998) 0.96
Isolation and sequence analysis of a cDNA clone encoding the fifth complement component. J Biol Chem (1985) 0.96
Structure of the human sialophorin (CD43) gene. Identification of features atypical of genes encoding integral membrane proteins. Biochem J (1990) 0.95
Fine mapping of the human pentraxin gene region on chromosome 1q23. Immunogenetics (1996) 0.92
Acute phase induction of mouse serum amyloid P component. Correlation with other parameters of inflammation. J Immunol (1989) 0.91
The human and mouse methylenetetrahydrofolate reductase (MTHFR) genes: genomic organization, mRNA structure and linkage to the CLCN6 gene. Gene (2000) 0.90
Mouse IL-1 receptor antagonist protein. Molecular characterization, gene mapping, and expression of mRNA in vitro and in vivo. J Immunol (1991) 0.90
Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy. Arterioscler Thromb Vasc Biol (2000) 0.90
The molecular basis for genetic deficiency of the second component of human complement. N Engl J Med (1985) 0.90
Haplotypic polymorphisms of the TNFB gene. Immunogenetics (1991) 0.90
The human serum amyloid A protein (SAA) superfamily gene cluster: mapping to chromosome 11p15.1 by physical and genetic linkage analysis. Genomics (1994) 0.89
Organization of the region encompassing the human serum amyloid A (SAA) gene family on chromosome 11p15.1. Genomics (1994) 0.88
Accurate and rapid "multiplex heteroduplexing" method for genotyping key enzymes involved in folate/homocysteine metabolism. Clin Chem (2000) 0.88
DNA polymorphism of MHC III genes in inbred and wild mouse strains. Immunogenetics (1987) 0.87
Use of the acute phase serum amyloid A2 (SAA2) gene promoter in the analysis of pro- and anti-inflammatory mediators: differential kinetics of SAA2 promoter induction by IL-1 beta and TNF-alpha compared to IL-6. J Immunol Methods (1997) 0.87
Major acute-phase reactant synthesis during chronic inflammation in amyloid-susceptible and -resistant mouse strains. Inflammation (1991) 0.86
The transcobalamin (TCN2) 776C>G polymorphism affects homocysteine concentrations among subjects with low vitamin B(12) status. Eur J Clin Nutr (2010) 0.86
Heterogeneous modulation of acute-phase-reactant mRNA levels by interleukin-1 beta and interleukin-6 in the human hepatoma cell line PLC/PRF/5. Biochem J (1991) 0.85
IL-1 and IL-6 mediate increased production and synthesis by hepatocytes of acute-phase reactant mouse serum amyloid P-component (SAP). Inflammation (1990) 0.85
Association between historically high frequencies of neural tube defects and the human T homologue of mouse T (Brachyury). Am J Med Genet (2000) 0.85
Competitive reverse transcription polymerase chain reaction for quantifying pre-mRNA and mRNA of major acute phase proteins. J Immunol Methods (1998) 0.84
Acute phase proteins in salmonids: evolutionary analyses and acute phase response. J Immunol (1997) 0.84
Structure and expression of the C3 gene. Springer Semin Immunopathol (1983) 0.84
Localization of four human serum amyloid A (SAA) protein superfamily genes to chromosome 11p: characterization of a fifth SAA-related gene sequence. Genomics (1993) 0.83
The mouse C-reactive protein gene maps to distal chromosome 1 and, like its human counterpart, is closely linked to the serum amyloid P component gene. Immunogenetics (1990) 0.83
Alcohol increases homocysteine and reduces B vitamin concentration in healthy male volunteers--a randomized, crossover intervention study. QJM (2008) 0.83
BELFAST centenarians: a case of optimised cardiovascular risk? Curr Pharm Des (2010) 0.82
Mapping genes within a YAC by computer-assisted interpretation of partial restriction digestions. Nucleic Acids Res (1996) 0.82
Polymorphisms of genes controlling homocysteine/folate metabolism and cognitive function. Neuroreport (2000) 0.81
Thermolabile MTHFR genotype and retinal vascular occlusive disease. Br J Ophthalmol (2001) 0.81
Genetic analysis of the thermolabile variant of 5, 10-methylenetetrahydrofolate reductase as a risk factor for ischemic stroke. Arterioscler Thromb Vasc Biol (1999) 0.81
Generation of soluble recombinant human acute phase serum amyloid A2 (A-SAA2) protein and its use in development of an A-SAA specific ELISA. J Immunol Methods (1996) 0.81
Characterization and acute phase modulation of canine apolipoprotein H (beta 2-glycoprotein I). Biochem Biophys Res Commun (1993) 0.81
A constitutively expressed serum amyloid A protein gene (SAA4) is closely linked to, and shares structural similarities with, an acute-phase serum amyloid A protein gene (SAA2). Genomics (1993) 0.81
Evolution of hemopoietic ligands and their receptors. Influence of positive selection on correlated replacements throughout ligand and receptor proteins. J Immunol (1996) 0.81
Reduced frequency of the thermolabile methylenetetrahydrofolate reductase genotype in the elderly. Atherosclerosis (1999) 0.80
Structure of the mouse serum amyloid A 5 (Saa5) gene: relationship to other members of the serum amyloid A family. Scand J Immunol (1997) 0.80
Dog serum amyloid A protein. Identification of multiple isoforms defined by cDNA and protein analyses. J Biol Chem (1991) 0.80
Twenty-first century phox: not yet ready for widespread screening. Circulation (2001) 0.80
Serum amyloid A transcription in Atlantic salmon (Salmo salar L.) hepatocytes is enhanced by stimulation with macrophage factors, recombinant human IL-1 beta, IL-6 and TNF alpha or bacterial lipopolysaccharide. Dev Comp Immunol (2000) 0.80
The thermolabile variant of 5,10-methylenetetrahydrofolate reductase is not associated with Parkinson's disease. J Neurol Neurosurg Psychiatry (1997) 0.80
Identification of a novel member of the pentraxin family in Xenopus laevis. Proc Biol Sci (1993) 0.80
Linkage between the loci for autosomal dominant neuronal Charcot-Marie-Tooth neuropathy (CMT1) and serum amyloid P component (APCS) on human chromosome 1. Cytogenet Cell Genet (1988) 0.79